These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24843084)

  • 21. Compression sclerotherapy for primary valvular insufficiency -from liquid to foam-.
    Yamaki T
    Ann Vasc Dis; 2010; 3(1):37-45. PubMed ID: 23555386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience with concomitant ultrasound-guided foam sclerotherapy and endovenous laser treatment in chronic venous disorder and its influence on Health Related Quality of Life: interim analysis of more than 1000 consecutive procedures.
    King T; Coulomb G; Goldman A; Sheen V; McWilliams S; Guptan RC
    Int Angiol; 2009 Aug; 28(4):289-97. PubMed ID: 19648872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.
    Ukritmanoroat T
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S35-40. PubMed ID: 21717876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of foam sclerotherapy for varicose veins: a survey of the members of the Vascular Society of Great Britain and Ireland.
    O'Hare JL; Earnshaw JJ
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):232-5. PubMed ID: 17507258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
    Tessari L; Cavezzi A; Frullini A
    Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The history of sclerosing foams.
    Wollmann JC
    Dermatol Surg; 2004 May; 30(5):694-703; discussion 703. PubMed ID: 15099310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technical feasibility and early results of radiologically guided foam sclerotherapy for treatment of varicose veins.
    Li L; Hong XY; Zeng XQ; Luo PL; Yi Q
    Dermatol Surg; 2011 Jul; 37(7):992-8. PubMed ID: 21585599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of endovenous foam sclerotherapy in the USA for the treatment of venous disorders: ACP/SVM/AVF/SIR quality improvement guidelines.
    Rathbun S; Norris A; Morrison N; Gibson K; Raymond-Martimbeau P; Worthington-Kirsch R; Hohenwalter E; Lohr J; McLafferty R; Stoner J
    Phlebology; 2014 Mar; 29(2):76-82. PubMed ID: 23390217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy.
    Ravi M; Kate V; Ananthakrishnan N
    Indian J Med Res; 2001 Jun; 113():228-33. PubMed ID: 11816957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    J Vasc Surg; 2008 Mar; 47(3):578-84. PubMed ID: 18295109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Investigation on the Influence of Hyaluronic Acid on Polidocanol Foam Stability.
    Chen AW; Liu YR; Li K; Liu SH
    Dermatol Surg; 2016 Jan; 42(1):56-8. PubMed ID: 26671207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sclerotherapy of craniofacial venous malformations: complications and results.
    Berenguer B; Burrows PE; Zurakowski D; Mulliken JB
    Plast Reconstr Surg; 1999 Jul; 104(1):1-11; discussion 12-5. PubMed ID: 10597669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sclerotherapy and foam sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurological and chest symptoms following sclerotherapy: a single centre experience.
    Hill DA
    Phlebology; 2014 Oct; 29(9):619-27. PubMed ID: 23945346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An investigation of coagulation cascade activation and induction of fibrinolysis using foam sclerotherapy of reticular veins.
    Fabi SG; Peterson JD; Goldman MP; Guiha I
    Dermatol Surg; 2012 Mar; 38(3):367-72. PubMed ID: 22092650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children.
    Stimpson P; Hewitt R; Barnacle A; Roebuck DJ; Hartley B
    Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):569-73. PubMed ID: 22341629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective randomised comparative study of visual foam sclerotherapy alone or in combination with ultrasound-guided foam sclerotherapy for treatment of superficial venous insufficiency: preliminary report.
    Yamaki T; Hamahata A; Soejima K; Kono T; Nozaki M; Sakurai H
    Eur J Vasc Endovasc Surg; 2012 Mar; 43(3):343-7. PubMed ID: 22230599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
    Li L; Feng J; Zeng XQ; Li YH
    J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foam and liquid sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009; 24 Suppl 1():62-72. PubMed ID: 19307442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.